Cancer survival in Lithuania after the restoration of independence: Rapid improvements, but persisting major gaps

References

• Cancer incidence in five continents. Volume VIII. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Lyon: IARC; 2002.
   Google Scholar
• Gondos A, Bray F, Brewster DH, Coebergh JW, Hakulinen T, Janssen-Heijnen ML, et al. Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. Eur J Cancer 2008;44:1463–75.
   PubMed Web of Science ®Google Scholar
• Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, et al. Up-to-date estimates of breast cancer survival for the years 2000–2004 in 11 European countries: The role of screening and a comparison with data from the United States. Eur J Cancer 2010;46:3351–7.
   PubMed Web of Science ®Google Scholar
• van de Schans SA, Gondos A, van Spronsen DJ, Rachtan J, Holleczek B, Zanetti R, et al. Improving relative survival, but large remaining differences in survival for non-Hodgkin’s lymphoma across Europe and the United States from 1990 to 2004. J Clin Oncol 2011;29:192–9.
   PubMed Web of Science ®Google Scholar
• Lithuanian 2011population Census in Brief. Vilnius: Statistics Lithuania; 2012.
   Google Scholar
• Statistics Lithuania. [cited June 2012]. Available from: http://www.stat.gov.lt/en.
   Google Scholar
• Brenner H, Gefeller O, Hakulinen T. Period analysis for ‘up-to-date’ cancer survival data: Theory, empirical evaluation, computational realisation and applications. Eur J Cancer 2004;40:326–35.
   PubMed Web of Science ®Google Scholar
• Berrino F, Brown C, Moller T, Sobin L, Faivre J. ENCR recommendations: Condensed TNM for coding the extent of disease. European Network of Cancer Registries (ENCR), 2002.
   Google Scholar
• Dickman PW. Estimating and modelling relative survival using Stata 2004 [cited 2013 June]. Available from: http://www.pauldickman.com/rsmodel/stata_colon/.
   Google Scholar
• Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epidemiol 2006;164:689–96.
   PubMed Web of Science ®Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980. Ann Oncol 2013; 24:2657–71.
   PubMed Web of Science ®Google Scholar
• Sandin S, Hjalgrim H, Glimelius B, Rostgaard K, Pukkala E, Askling J. Incidence of non-Hodgkin’s lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: An epidemic that was.Cancer Epidemiol Biomarkers Prev 2006;15:1295–300.
   PubMed Web of Science ®Google Scholar
• Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 2002;94: 2015–23.
   PubMed Web of Science ®Google Scholar
• Gondos A, Bray F, Hakulinen T, Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: A model-based analysis. Ann Oncol 2009;20:564–73.
   PubMed Web of Science ®Google Scholar
• Janssen-Heijnen ML, Gondos A, Bray F, Hakulinen T, Brewster DH, Brenner H, et al. Clinical relevance of conditional survival of cancer patients in Europe: Age-specific analyses of 13 cancers. J Clin Oncol 2010;28:2520–8.
   PubMed Web of Science ®Google Scholar
• Znaor A, Bray F. Thirty year trends in testicular cancer mortality in Europe: Gaps persist between the East and West. Acta Oncol 2012;51:956–8.
   PubMed Web of Science ®Google Scholar
• Brenner H, Francisci S, de Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, et al. Long-term survival expectations of cancer patients in Europe in 2000–2002. Eur J Cancer 2009;45:1028–41.
   PubMed Web of Science ®Google Scholar
• Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, et al. EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14(Suppl 5):v128–49.
   PubMed Web of Science ®Google Scholar
• Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in Europe: A 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784–96.
   PubMed Web of Science ®Google Scholar
• Verhoeven RH, Gondos A, Janssen-Heijnen ML, Saum KU, Brewster DH, Holleczek B, et al. Testicular cancer in Europe and the USA: Survival still rising among older patients. Ann Oncol 2013;24:508–13.
   PubMed Web of Science ®Google Scholar
• Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007. Acta Oncol 2013;52:919–32.
   PubMed Web of Science ®Google Scholar
• Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009;45:931–91.
   PubMed Web of Science ®Google Scholar
• Smailyte G, Aleknaviciene B. Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme. Public Health 2012;126:1075–7.
   PubMed Web of Science ®Google Scholar
• Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, et al. Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context. J Natl Cancer Inst 2009;101:374–83.
   PubMedGoogle Scholar
• Lemmens VE, Bosscha K, van der Schelling G, Brenninkmeijer S, Coebergh JW, de Hingh IH. Improving outcome for patients with pancreatic cancer through centralization. Br J Surg 2011;98:1455–62.
   PubMed Web of Science ®Google Scholar